Mansoor Raza Mirza - Oct 1, 2025 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role: Chief Medical Officer
Signature: /s/ Adam D. Levy, Attorney-in-Fact
Stock symbol: ACRV
Transactions as of: Oct 1, 2025
Transactions value $: $0
Form type: 4
Date filed: 10/3/2025, 04:28 PM
Previous filing: Sep 5, 2025
Next filing: Oct 6, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mirza Mansoor Raza	Chief Medical Officer	C/O ACRIVON THERAPEUTICS, INC., 480 ARSENAL WAY, SUITE 100, WATERTOWN	/s/ Adam D. Levy, Attorney-in-Fact	2025-10-03	0001588389

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACRV	Stock Option (Right to Buy)	Award	$0	+225K		$0.00	225K	Oct 1, 2025	Common Stock	225K	$1.81	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of the shares subject to the option vest on November 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.